p47(phox) contributes to albuminuria and kidney fibrosis in mice
- PMID: 25565313
- PMCID: PMC4425591
- DOI: 10.1038/ki.2014.386
p47(phox) contributes to albuminuria and kidney fibrosis in mice
Abstract
Reactive oxygen species (ROS) have an important pathogenic role in the development of many diseases, including kidney disease. Major ROS generators in the glomerulus of the kidney are the p47(phox)-containing NAPDH oxidases NOX1 and NOX2. The cytosolic p47(phox) subunit is a key regulator of the assembly and function of NOX1 and NOX2 and its expression and phosphorylation are upregulated in the course of renal injury, and have been shown to exacerbate diabetic nephropathy. However, its role in nondiabetic-mediated glomerular injury is unclear. To address this, we subjected p47(phox)-null mice to either adriamycin-mediated or partial renal ablation-mediated glomerular injury. Deletion of p47(phox) protected the mice from albuminuria and glomerulosclerosis in both injury models. Integrin α1-null mice develop more severe glomerulosclerosis compared with wild-type mice in response to glomerular injury mainly due to increased production of ROS. Interestingly, the protective effects of p47(phox) knockout were more profound in p47(phox)/integrin α1 double knockout mice. In vitro analysis of primary mesangial cells showed that deletion of p47(phox) led to reduced basal levels of superoxide and collagen IV production. Thus, p47(phox)-dependent NADPH oxidases are a major glomerular source of ROS, contribute to kidney injury, and are potential targets for antioxidant therapy in fibrotic disease.
Figures
References
-
- Schell C, Huber TB. New players in the pathogenesis of focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2012;27:3406–3412. - PubMed
-
- Modlinger PS, Wilcox CS, Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol. 2004;24:354–365. - PubMed
-
- Coaccioli S, Crapa G, Fantera M, et al. Oxidant/antioxidant status in patients with chronic HIV infection. Clin Ter. 2010;161:55–58. - PubMed
MeSH terms
Substances
Grants and funding
- I01 BX000320/BX/BLRD VA/United States
- R01 DK069921/DK/NIDDK NIH HHS/United States
- P01 DK038226/DK/NIDDK NIH HHS/United States
- R01 DK095785/DK/NIDDK NIH HHS/United States
- I01 BX002025/BX/BLRD VA/United States
- R01 DK075594/DK/NIDDK NIH HHS/United States
- R01 HL085317/HL/NHLBI NIH HHS/United States
- R01 DK051265/DK/NIDDK NIH HHS/United States
- R01 DK083187/DK/NIDDK NIH HHS/United States
- R01 DK062794/DK/NIDDK NIH HHS/United States
- I01 BX002196/BX/BLRD VA/United States
- P01 HL092870/HL/NHLBI NIH HHS/United States
- R01 DK095761/DK/NIDDK NIH HHS/United States
- R01 CA162433/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
